CSIMarket
 


Vbi Vaccines Inc  (VBIV)
Other Ticker:  
 

Cumulative Vbi Vaccines Inc's Leverage Ratio for Trailing Twelve Months Period

VBIV's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

VBIV Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -76.27 % -91.72 % -65.25 % -55.41 % -47.66 %
Y / Y Total Liabilities Growth -7.11 % 13.38 % 22.49 % 29.27 % 29.67 %
Leverage Ratio for Trailing Twelve Months Period 2.3 1.6 1.05 0.78 0.61
Total Ranking # 2843 # 2545 # 2058 # 1879 # 1491
Seq. Equity Growth 127.58 % -80.59 % -29.83 % -23.45 % -20.6 %
Seq. Total Liabilities Growth 2.23 % -4.33 % -8.04 % 3.29 % 24.77 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to net new borrowings of 2.23%, Leverage Ratio for Trailing Twelve Months Period improved to 2.3, above Vbi Vaccines Inc's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 397 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Vbi Vaccines Inc. While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are VBIV's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 398
Sector # 810
S&P 500 # 3188


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.43 0.5 0.23
(Sep 30 2023)   (Mar 31 2021)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Aslan Pharmaceuticals Limited  6.31 
Puma Biotechnology Inc   6.31 
Nabriva Therapeutics Plc  6.19 
Abbvie inc   6.18 
Zyversa Therapeutics Inc   6.00 
Soligenix inc   5.64 
Kala Bio inc   5.42 
Ionis Pharmaceuticals Inc  5.16 
Collegium Pharmaceutical Inc   5.14 
Harrow Inc   5.09 
Therapeuticsmd Inc   5.03 
Nrx Pharmaceuticals Inc   4.99 
Cingulate Inc   4.98 
Adc Therapeutics Sa  4.96 
Amicus Therapeutics inc   4.95 
Alimera Sciences Inc   4.88 
Cv Sciences Inc   4.87 
Intercept Pharmaceuticals inc   4.85 
Ultragenyx Pharmaceutical Inc   4.79 
Lifecore Biomedical Inc   4.72 
Journey Medical Corporation  4.69 
Clene Inc   4.66 
Ocular Therapeutix Inc   4.50 
Travere Therapeutics Inc   4.50 
Ironwood Pharmaceuticals inc   4.46 
Sarepta Therapeutics Inc   4.29 
Janone Inc   4.05 
Eterna Therapeutics Inc   3.98 
Teva Pharmaceutical Industries Limited  3.92 
9 Meters Biopharma Inc   3.75 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com